Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): Possible involvement in neurodegenerative processes

Molecular Psychiatry

Volumn 2, Issue 2, 1997, Pages 107-110

  Giraudon, P ^a   Buart, S ^a   Bernard, A ^a   Belin, M F ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MYELIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CELL SECRETION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SPINAL CORD DISEASE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 0030935958     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000218     Document Type: Article

References (23)

1. Gessain A, Vernant JC, Barin F, Maurs L. Antibodies to human T lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985; ii: 407-409.
2. Kubota R, Umehara F, Izumo S, Ijichi S, Matsumuro K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M. HTLV-1 proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol 1994; 53: 23-29.
3. Lecky T, Fox C, Koenig S, Levin M, Fleslarge N, Izumo S, Sato E, Raire C, Osame M, Jacobson S. Detection of human T-lymphotropic virus type 1 (HTLV-I) Tax mRNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridation. Ann Neurol 1995; 37: 167-175.
4. Nishimoto N, Yoshizaki K, Eiraku K, Machigashira K, Tagoh H, Ogata A, Kurritani T, Osame M, Kishimoto T. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myolopathy/tropical spastic paraparesis. J Neurol Sci 1990; 97: 183-193.
5. Frei K, Malipiero V, Leist P, Zinkernagel R, Swab M, Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system. Eur J Immunol 1989; 19: 689-696.
6. Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1994; 53: 424-430.
7. Giraudon P, Dufay N, Hardin H, Reboul A, Tardy M, Belin MF. Differentiation of a medulloblastoma cell line towards an astrocytic lineage using the humanT lymphotrophic retrovirus-1. Neuroscience 1993; 52: 1069-1079.
8. Akaoka H, Hardin-Pouzet H, Bernard B, Verrier B, Belin MF, Giraudon P. Imbalanced expression of glutamate-glutamine cycle enzymes induced in astrocytes by HTLV-I infection: implication of the Tax protein. J Virol 1996; 70: 8727-8736.
9. Giraudon P, Bernard A, Malcus C, Dufay N, Desgranges C, Belin MF. Retroviral infection (HTLV-I) induces cytokine-regulated immunomodulation and cytotoxicity of medulloblastoma cells. J Neuropathol Exp Neurol 1995; 54: 165-174.
10. Matrisian LM. The matrix-degrading metalloproteinases. Bioassay 1992; 14: 455-463.
11. Kleiner DE, Stetler-Stevenson WG. Structural biochemistry and activation of metalloproteinases. Curr Opin Cell Biol 1993; 5: 891-897.
12. Apocada G, Rutka JT, Boukana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH, Banda MJ. Expression of metalloproteinases and metalloproteinases inhibitors by fetal astrocytes and glioma cells. Cancer Res 1990; 50: 2322-2339.
13. Nakano A, Tani E, Miyazaki A, Yamamoto Y, Furuyama JI. Matrix metalloproteinases and tissue inhibitor of metalloproteinases in human gliomas. J Neurosurg 1995; 83: 298-307.
14. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gel containing sodium dodecyl sulphate and copolymerized substrates. Anal Biochem 1980; 102: 196-202.
15. Alexandre C, Verrier B. c-fos promoter mediated trans-activation by HTLV-I Tax protein. Oncogene 1991; 6: 543-551.
16. Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993; 8: 395-405.
17. Partridge CA, Jeffrey JJ, Malik AB. A 96 kDa gelatinase induced by TNF-a contributes to increased microvascular endothelial permeability. Am J Physiol 1993; 265 (Lung Cell Mol Physiol 9): L438-L447.
18. Rosenberg G, Kornfeld M, Estrada E, Kelly R, Liotta L, Stetler-Stevenson WG. TIMP-2 reduces proteolytic opening of blood-brain barrier. Brain Res 1992; 576: 203-207.
19. Höllesberg P, Hafler DA. What is the pathogenosis of human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis? Ann Neurol 1995; 37: 143-145.
20. Seeds N, Williams B, Bickford B. Tissue plasminogen activator in Purkinje neurons after cerebellum motor learning. Science 1995; 270: 1992-1994.
21. Gijbel K, Proost P, Masure S, Carton H, Billiau A, Opdenakker G. Gelatinase A is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res 1993; 36: 432-440.
22. Gijbel SK. Reversal of experimental autoimmune encephalomyelitis with a hydroxarnate inhibitor of matrix metalloproteases. J Clin Invest 1994; 94: 2177-2182.
23. Gearing AJH, Beckett P, Ghistodoulou M, Churchill M, Clements JM, Crimmin M, Davidson AH, Drummond AH et al. Matrix metalloproteinases and processing of proTNFα. J Leukocyte Biol 1995; 57: 744-777.